ImmunityBio Inc: hAd5-Covid-19
Vaccine Type: Non Replicating Viral Vector
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 1 trials.
About Trial Phases
Phase 2:
0
Trials
There are no trials for this phase.
Phase 3:
0
Trials
There are no trials for this phase.
Approvals:
0
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT04710303
Phase 1
South Africa
Total Enrollment: 35
Official Trial Registration:
-
NCT04732468
Phase 1
United States of America
Total Enrollment: 65
Official Trial Registration:
-
NCT04591717
Phase 1
United States of America
Total Enrollment: 35
Official Trial Registration:
